China vs Zimbabwe: Treatment success rate for patients treated for MDR-TB
China
68.0%
in 2022
Zimbabwe
69.0%
in 2022
China rank
104th
Zimbabwe rank
101st
Treatment success rate for patients treated for MDR-TB over time
- China
- Zimbabwe
How they compare
Zimbabwe currently reports 69.0% against 68.0% in China, a difference of 1.0%.
The two have swapped places 2 times across 14 shared years of data; in 2009 it was Zimbabwe ahead.
China ranks 104th and Zimbabwe ranks 101st of 163 countries.
Across the 3 decades both report, China averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | China | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 100.0% | 54.0% | Zimbabwe |
| 2010s | 48.4% | 58.1% | 9.7% | Zimbabwe |
| 2020s | 61.7% | 59.7% | 2.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, China or Zimbabwe?
- Zimbabwe, at 69.0% against 68.0% in China as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between China and Zimbabwe?
- 1.0%, with Zimbabwe ahead.
- How many years of comparable data are there for China and Zimbabwe?
- 14 years are reported by both, from 2009 to 2022.
- How do China and Zimbabwe rank globally for treatment success rate for patients treated for mdr-tb?
- China ranks 104th and Zimbabwe ranks 101st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.